missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18152004

HYPE Antibody (OTI2A11), Alexa Fluor™ 700, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-71681AF700

Product Code. 18152004

  • € 751.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

HYPE Monoclonal specifically detects HYPE in Human, Mouse, Rat samples. It is validated for Western Blot.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

HYPE
Monoclonal
Alexa Fluor 700
50mM Sodium Borate with 0.05% Sodium Azide
FICD
Recombinant protein fragment corresponding to amino acids 61-265 of human HYPE (NP_009007) produced in E.coli.
0.1 mL
Primary
Human, Mouse, Rat
IgG1
Western Blot
OTI2A11
Western Blot
AMPylator FICD, EC 2.7.7.n1, FIC domain containing, FIC domain-containing protein, fic S-phase protein cell division homolog, HIP-13, HIP13UNQ3041, huntingtin interacting protein 13, Huntingtin interacting protein E, huntingtin interactor protein E, Huntingtin yeast partner E, Huntingtin-interacting protein 13, Huntingtin-interacting protein E, HYPEadenosine monophosphate-protein transferase FICD, MGC5623
Mouse
Affinity Purified
Cell Cycle and Replication
11153.0
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.